Evidence map›Paper›PMID 35289328›Full record

ArticleNature chemical biology2022

Symmetric and asymmetric receptor conformation continuum induced by a new insulin.

Xiaochun Xiong, Alan Blakely, Jin Hwan Kim, John G Menting, Ingmar B Schäfer, Heidi L Schubert, Rahul Agrawal, Theresia Gutmann, Carlie Delaine, Yi Wolf Zhang and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Toxins in disguise: Neuropeptide mimicry across animal venoms.General and comparative endocrinology · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Modulation of the antagonistic properties of an insulin mimetic peptide by disulfide bridge modifications.Journal of peptide science : an official publication of the European Peptide Society · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 4 countries.

Xiaochun Xiong *Department of Pediatrics, Division of Endocrinology and Diabetes, Stanford University, Stanford, CA, USA.
Alan Blakely *Department of Biochemistry, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0002-8066-7870
Jin Hwan KimDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.
John G MentingWEHI, Parkville, Victoria, Australia.
Ingmar B SchäferDepartment of Structural Cell Biology, Max Planck Institute of Biochemistry, Munich, Germany.ORCID http://orcid.org/0000-0002-7301-7300
Heidi L SchubertDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.
Rahul AgrawalDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Theresia GutmannPaul Langerhans Institute Dresden, Helmholtz Zentrum München, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0003-0562-2880
Carlie DelaineDiscipline of Medical Biochemistry and Cell Biology, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia.
Yi Wolf ZhangDepartment of Pediatrics, Division of Endocrinology and Diabetes, Stanford University, Stanford, CA, USA.
Gizem Olay ArtikPaul Langerhans Institute Dresden, Helmholtz Zentrum München, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-3667-2955
Allanah MerrimanDiscipline of Medical Biochemistry and Cell Biology, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia.
Debbie EckertDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA.
Michael C LawrenceWEHI, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0003-1999-0801
Ünal CoskunPaul Langerhans Institute Dresden, Helmholtz Zentrum München, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Simon J FisherDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Briony E ForbesDiscipline of Medical Biochemistry and Cell Biology, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia.ORCID http://orcid.org/0000-0003-4360-9927
Helena Safavi-HemamiDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA. safavihelena@sund.ku.dk.ORCID http://orcid.org/0000-0002-1984-2721
Christopher P HillDepartment of Biochemistry, University of Utah, Salt Lake City, UT, USA. chris@biochem.utah.edu.ORCID http://orcid.org/0000-0001-6796-7740
Danny Hung-Chieh ChouDepartment of Pediatrics, Division of Endocrinology and Diabetes, Stanford University, Stanford, CA, USA. dannychou@stanford.edu.ORCID http://orcid.org/0000-0001-9110-614X
University of Utah · USDeutsches Diabetes-Zentrum e.V. · DEFlinders University · AUThe University of Melbourne · AUMax Planck Institute of Biochemistry · DEUniversity of Copenhagen · DKUniversity of Kentucky · US

Funding

DEVELOPMENT OF CONCENTRATED, STABLE ULTRA FAST-ACTING INSULIN FORMULATIONR01DK120430 · NIDDK · UNIVERSITY OF UTAH · PI CHOU, DANNY HUNG-CHIEH · 2018 to 2021
$2.2M
STUDIES ON INSULIN RECEPTOR ISO FORMSR35GM125001 · NIGMS · UNIVERSITY OF UTAH · PI CHOU, DANNY HUNG-CHIEH · 2017 to 2021
$2.0M
Structural Insights to Insulin Receptor Ligand InteractionsR01DK127268 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HILL, CHRISTOPHER P. · 2021 to 2025
$1.9M
Pharmacological Approach to the Restoration of Hypoglycemia AwarenessR01DK118082 · NIDDK · UNIVERSITY OF UTAH · PI FISHER, SIMON J · 2019 to 2023
$1.9M
NIDDK NIH HHS R01 DK118082NIDDK NIH HHS R01 DK120430NIDDK NIH HHS R01 DK127268NIGMS NIH HHS R35 GM125001
6 · The paper itself

Abstract

Cone snail venoms contain a wide variety of bioactive peptides, including insulin-like molecules with distinct structural features, binding modes and biochemical properties. Here, we report an active humanized cone snail venom insulin with an elongated A chain and a truncated B chain, and use cryo-electron microscopy (cryo-EM) and protein engineering to elucidate its interactions with the human insulin receptor (IR) ectodomain. We reveal how an extended A chain can compensate for deletion of B-chain residues, which are essential for activity of human insulin but also compromise therapeutic utility by delaying dissolution from the site of subcutaneous injection. This finding suggests approaches to developing improved therapeutic insulins. Curiously, the receptor displays a continuum of conformations from the symmetric state to a highly asymmetric low-abundance structure that displays coordination of a single humanized venom insulin using elements from both of the previously characterized site 1 and site 2 interactions.

Indexed as

InsulinMollusk VenomsCryoelectron MicroscopyHumansPeptidesProtein ConformationInsulinMollusk VenomsPeptides

Identifiers

PMID35289328
PMCPMC9248236
OpenAlexW4221132537

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.